文献速递神经肿瘤

激光间质热疗作为岛叶胶质瘤一线治疗

Laser interstitial thermal therapy for first-line treatment of insular glioma.
PubMed 文献 · J Neurosurg · 2024-05-24

作者报告2015至2023年前瞻性登记数据库中22例初治岛叶胶质瘤患者接受激光间质热疗(LITT)的经验,提出按肿瘤大小及岛叶外累及范围分层的新框架:仅岛叶肿瘤单用LITT,岛叶伴额颞受累者行岛叶LITT联合岛叶外肿瘤切除。结果显示LITT可行且可能获得高比例肿瘤减容。

要点

  • 仅岛叶肿瘤中位体积13.4 cm3,中位治疗范围100%,均于消融次日出院。
  • 岛叶伴额颞受累者肿瘤更大(中位81.2 cm3),50%住院超过3天,33%遗留永久性神经功能缺损。
  • 4级肿瘤永久性神经功能缺损率43%,术后Karnofsky功能评分下降更大(p = 0.046)。

核心结论

  • 作者认为将LITT纳入岛叶胶质瘤手术框架可行,可能实现高比例肿瘤减容,并可能降低传统岛叶胶质瘤手术的风险。

研究设计与样本

  • 前瞻性收集的本机构数据库,纳入2015至2023年间新诊断并接受LITT的岛叶胶质瘤患者。
  • 共33例LITT手术,涉及22例初治岛叶胶质瘤患者;12例为仅岛叶肿瘤,10例为岛叶伴额颞受累。
  • 仅岛叶肿瘤行单次或分期LITT;岛叶伴额颞受累者行岛叶LITT联合岛叶外肿瘤的标准化额颞切除。

主要发现

  • 仅岛叶肿瘤中位体积13.4 cm3(IQR 10.6,26.3 cm3),中位治疗范围100%(IQR 92.1%,100%)。
  • 岛叶伴额颞受累病灶中位体积81.2 cm3(IQR 51.9,97 cm3),中位治疗范围96.6%(IQR 93.7%,100%)。
  • 仅岛叶肿瘤患者均于消融次日出院;岛叶伴额颞受累患者住院时间显著更长,50%住院超过3天。
  • 仅岛叶肿瘤患者8%出现永久性神经功能缺损,岛叶伴额颞受累患者为33%。
  • 随访中2例肿瘤进展:1例WHO 4级星形细胞瘤,1例弥漫性胶质瘤未另作分类。

临床怎么用

  • 作者提出的框架以肿瘤大小和岛叶外肿瘤累及范围指导术式选择:仅岛叶肿瘤行单次或分期LITT,岛叶伴额颞受累者行岛叶LITT联合岛叶外肿瘤切除。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Insular gliomas pose a significant surgical challenge due to the complex surrounding functional and vascular anatomy. The authors report their experience using a novel framework for the treatment of insular gliomas with laser interstitial thermal therapy (LITT) and provide representative case examples emphasizing indications, rationale, and technical pearls. METHODS: A prospectively gathered institutional database was used to identify patients with newly diagnosed insular gliomas who underwent LITT between 2015 and 2023. The proposed framework of insular glioma management is guided by tumor size and extent of extra-insular tumor involvement. Patients with tumors localized to the insula (insula-only) were treated with single-session or staged LITT. Patients with insular tumors with frontotemporal involvement (insular+) were treated with insular LITT and standard frontotemporal resection of extra-insular tumor. Clinical and volumetric lesional characteristics were analyzed, with particular emphasis on extent of cytoreductive treatment and safety. RESULTS: Of the 261 patients treated at the authors' institution with LITT between 2015 and 2023, 33 LITT procedures were identified involving 22 unique patients with treatment-naive insular gliomas. Of the 22 patients, 12 had insular-only tumors and were treated with LITT alone, while 10 patients had insular+ lesions and were treated with LITT and resection. The median tumor volume for insular-only tumors was 13.4 cm3 (IQR 10.6, 26.3 cm3), with a median extent of treatment of 100% (IQR 92.1%, 100%). Insular+ lesions were significantly larger, with a median volume of 81.2 cm3 (IQR 51.9, 97 cm3) and median extent of treatment of 96.6% (IQR 93.7%, 100%). All patients with insular-only tumors were discharged the day after ablation, while insular+ patients had significantly longer hospital stays, with 50% staying more than 3 days. Overall, 8% of insular-only patients had permanent neurological deficits compared with 33% of insular+ patients. Two patients' tumors progressed during follow-up: one patient with WHO grade 4 astrocytoma and the other with diffuse glioma not otherwise specified. Patients with grade 4 tumors had the highest rate of permanent neurological deficit (43%) and a larger decline in postoperative Karnofsky Performance Status score (p = 0.046). CONCLUSIONS: The authors present their experience using a novel insular glioma treatment paradigm that incorporates LITT into the broader framework of insular glioma surgery. Their findings suggest that insular LITT is feasible and may allow for high rates of cytoreduction while potentially ameliorating the risks of conventional insular glioma surgery.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Fadel HA, Pawloski JA, Anzalone AJ, et al. Laser interstitial thermal therapy for first-line treatment of insular glioma. J Neurosurg. 2024. PMID: 38788240. doi:10.3171/2024.2.JNS232807

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。